SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA

Lancet. 2020 Oct 24;396(10259):1308-1309. doi: 10.1016/S0140-6736(20)32006-7. Epub 2020 Sep 25.

Authors

Barnaby Flower¹, Christina Atchison²

Affiliations

¹ Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1NY, UK. Electronic address: b.flower@imperial.ac.uk.
² School of Public Health, Imperial College London, London, UK.

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Viral
COVID-19*
Humans
Renal Dialysis / adverse effects
SARS-CoV-2*
Seroepidemiologic Studies
United States / epidemiology

Substances

Antibodies, Viral